This is thanks to advances in bulk and single-cell RNA-sequencing (RNA-seq) technologies that can capture every RNA molecule expressed in a cell: its transcriptome. The computational methods ...

Due for release in 2026, the US company’s technology for whole-transcriptome sequencing will allow researchers to examine the spatial proximity of millions of cells per experiment due to a ...

Not only does our body change with age, but so does our immune system. A recent study led by the Centre for Individualised Infection Medicine (CiiM) shows exactly how immune cells age and how ...

RNA sequencing has emerged as a powerful supplement to DNA sequencing for Mendelian disease diagnosis, but clinical translation of diagnostic RNA-seq ...

MINNEAPOLIS, Feb. 20, 2025 /PRNewswire/ -- Bio-Techne (NASDAQ: TECH), a global leader in life science tools and reagents, today announced the launch of an expanded menu of human and mouse RNAscope ...

Parse Biosciences affirms plans to proceed with development and future release of their Evercode™ single cell chromatin products.

Low-depth long-read transcriptome sequencing, with only 10,000s of reads per sample, is sufficient to assemble hundreds of highly expressed genes, including all or nearly all mitochondrial ...

Single-cell multiomic analyses reveal known and new genes and pathways involved in the development of germ cells and provide a discovery platform for the scientific community.

This comes on the heels of Parse invalidating the patents that 10x Genomics had asserted against Parse’s Evercode Whole Transcriptome products and the subsequent cancellation of a trial on those ...